Synapse - Works

Results (116513)

Next-generation DNA sequencing (NGS) results for tumours from phase II ABRAZO study of talazoparib after platinum or cytotoxic non-platinum regimens in patients (pts) with advanced breast cancer (ABC) and germline BRCA1/2 (gBRCA) mutations

Meeting Abstract

Turner, N. C.; Laird, A. D.; Telli, M. L.; Rugo, H. S.; Mailliez, A.; Ettl, J.; Grischke, E. M.; Mina, L. A.; Balmaña, J.; Fasching, P. A.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

METEOR-1: A phase I study GSK3326595, a first-in-class protein arginine methyltransferase 5 (PRMT5) inhibitor, in advanced solid tumours

Meeting Abstract

Siu, L. L.; Rasco, D. W.; Postel Vinay, S.; Martin Romano, P.; Menis, J.; Opdam, F. L.; Heinhuis, K. M.; Egger, J. L.; Gorman, S. A.; Parasrampuria, R.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

Trastuzumab and tucatinib for the treatment of HER2 amplified metastatic colorectal cancer (mCRC): Initial results from the MOUNTAINEER trial

Meeting Abstract

Strickler, J. H.; Zemla, T.; Ou, F. S.; Cercek, A.; Wu, C.; Sanchez, F. A.; Hubbard, J.; Jaszewski, B.; Bandel, L.; Schweitzer, B.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

Phase III, international, multicenter, randomized, open-label trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) vs gemcitabine (G) alone for surgically resected pancreatic adenocarcinoma (APACT): Subgroup analyses

Meeting Abstract

Tempero, M. A.; Reni, M.; Riess, H.; O'Reilly, E. M.; Krishnamurthi, S.; Österlund, P.; Ales-Diaz, I. C.; Milella, M.; Siena, S.; Tabernero, J.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

Randomized phase III trial of avelumab + axitinib vs sunitinib as first-line treatment for advanced renal cell carcinoma: JAVELIN renal 101 Japanese subgroup analysis

Meeting Abstract

Uemura, M.; Tomita, Y.; Miyake, H.; Hatakeyama, S.; Kanayama, H. O.; Numakura, K.; Takagi, T.; Kato, T.; Eto, M.; Obara, W.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

Phase III trial of adjuvant sunitinib in patients with high-risk renal cell carcinoma: Comprehensive tumour genomic and transcriptomic analyses

Meeting Abstract

Ravaud, A.; Martini, J. F.; Ching, K.; Staehler, M.; Magheli, A.; Escudier, B.; Mu, X. J.; Valota, O.; Lin, X.; Motzer, R. J.
Annals of Oncology (2019)

Fulltext@MSK | Save

Phase II study of 2 dosing regimens of cemiplimab, a human monoclonal anti-PD-1, in metastatic cutaneous squamous cell carcinoma (mCSCC)

Meeting Abstract

Rischin, D.; Lim, A. M.; Schmults, C. D.; Khushalani, N. I.; Hughes, B. G.; Schadendorf, D.; Dunn, L. A.; Chang, A. L. S.; Hauschild, A.; Ulrich, C.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

A phase II basket study of MCLA-128, a bispecific antibody targeting the HER3 pathway, in NRG1 fusion-positive advanced solid tumours

Meeting Abstract

Schram, A. M.; Drilon, A.; Macarulla Mercade, T.; O'Reilly, E. M.; Rodon, J. A.; Wolpin, B. M.; Ou, S. H. I.; Kim, D. W.; Yang, J. C. H.; Lam, Y. C. J.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

Analysis of BRCA genes and homologous recombination deficiency (HRD) scores in tumours from patients (pts) with metastatic breast cancer (mBC) in the OlympiAD trial

Meeting Abstract

Robson, M.; Lai, Z.; Dearden, S.; Barrett, J. C.; Harrington, E. A.; Timms, K.; Lanchbury, J.; Wu, W.; Allen, A.; Goessl, C.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

Prognostic and predictive factors from the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in previously treated advanced hepatocellular carcinoma (aHCC)

Meeting Abstract

Meyer, T.; Kelley, R. K.; Mangeshkar, M.; Cheng, A. L.; El-Khoueiry, A. B.; Abou-Alfa, G. K.
Annals of Oncology (2019)

Fulltext@MSK | Save